First Time Loading...
A

Anhui Huaheng Biotechnology Co Ltd
SSE:688639

Watchlist Manager
Anhui Huaheng Biotechnology Co Ltd
SSE:688639
Watchlist
Price: 120.98 CNY -2.22% Market Closed
Updated: May 11, 2024
Section:
 

Wall Street
Price Targets

Price Targets Summary
Anhui Huaheng Biotechnology Co Ltd

Wall Street analysts forecast Anhui Huaheng Biotechnology Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Anhui Huaheng Biotechnology Co Ltd is 138.44 CNY with a low forecast of 127.3 CNY and a high forecast of 147 CNY.

Lowest Forecast
Wall Street Target
127.3 CNY
5% Upside
Average Forecast
Wall Street Target
138.44 CNY
14% Upside
Highest Forecast
Wall Street Target
147 CNY
22% Upside
Lowest
Price Target
127.3 CNY
5% Upside
Average
Price Target
138.44 CNY
14% Upside
Highest
Price Target
147 CNY
22% Upside
Anhui Huaheng Biotechnology Co Ltd Competitors:
Price Targets
5122
Okamoto Industries Inc
4% Downside
A
161000
AekyungChemical Co Ltd
25% Upside
VVV
Valvoline Inc
10% Upside
1314
China Petrochemical Development Corp
309% Upside
5122
Okamoto Industries Inc
4% Downside
A
161000
AekyungChemical Co Ltd
25% Upside
VVV
Valvoline Inc
10% Upside
1314
China Petrochemical Development Corp
309% Upside
SDV
Scidev Ltd
49% Upside
HSCL
Himadri Speciality Chemical Ltd
35% Downside
I
INDIAGLYCO
India Glycols Ltd
72% Upside
2103
TSRC Corp
28% Upside

Revenue
Forecast

Revenue Estimate
Anhui Huaheng Biotechnology Co Ltd

For the last 9 years the compound annual growth rate for Anhui Huaheng Biotechnology Co Ltd's revenue is 26%. The projected CAGR for the next 4 years is 38%.

26%
Past Growth
38%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Anhui Huaheng Biotechnology Co Ltd

For the last 9 years the compound annual growth rate for Anhui Huaheng Biotechnology Co Ltd's operating income is 38%. The projected CAGR for the next 4 years is 39%.

38%
Past Growth
39%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Anhui Huaheng Biotechnology Co Ltd

For the last 9 years the compound annual growth rate for Anhui Huaheng Biotechnology Co Ltd's net income is 43%. The projected CAGR for the next 4 years is 35%.

43%
Past Growth
35%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Anhui Huaheng Biotechnology Co Ltd's stock price target?
Price Target
138.44 CNY

According to Wall Street analysts, the average 1-year price target for Anhui Huaheng Biotechnology Co Ltd is 138.44 CNY with a low forecast of 127.3 CNY and a high forecast of 147 CNY.

What is Anhui Huaheng Biotechnology Co Ltd's Revenue forecast?
Projected CAGR
38%

For the last 9 years the compound annual growth rate for Anhui Huaheng Biotechnology Co Ltd's revenue is 26%. The projected CAGR for the next 4 years is 38%.

What is Anhui Huaheng Biotechnology Co Ltd's Operating Income forecast?
Projected CAGR
39%

For the last 9 years the compound annual growth rate for Anhui Huaheng Biotechnology Co Ltd's operating income is 38%. The projected CAGR for the next 4 years is 39%.

What is Anhui Huaheng Biotechnology Co Ltd's Net Income forecast?
Projected CAGR
35%

For the last 9 years the compound annual growth rate for Anhui Huaheng Biotechnology Co Ltd's net income is 43%. The projected CAGR for the next 4 years is 35%.

ALPHA SPREAD
Join more than 136,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.